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Abstract
Neuropeptide signaling plays roles in coordinating cellular activities and maintaining robust oscillations within the
mammalian suprachiasmatic nucleus (SCN). Prokineticin2 (PK2) is a signaling molecule from the SCN and involves in the
generation of circadian locomotor activity. Prokineticin receptor 2 (PKR2), a receptor for PK2, has been shown to be
expressed in the SCN. However, very little is known about the cellular action of PK2 within the SCN. In the present study, we
investigated the effect of PK2 on spontaneous firing and miniature inhibitory postsynaptic currents (mIPSCs) using whole
cell patch-clamp recording in the SCN slices. PK2 dose-dependently increased spontaneous firing rates in most neurons
from the dorsal SCN. PK2 acted postsynaptically to reduce c-aminobutyric acid (GABA)-ergic function within the SCN, and
PK2 reduced the amplitude but not frequency of mIPSCs. Furthermore, PK2 also suppressed exogenous GABA-induced
currents. And the inhibitory effect of PK2 required PKC activation in the postsynaptic cells. Our data suggest that PK2 could
alter cellular activities within the SCN and may influence behavioral and physiological rhythms.
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Introduction
The mammalian suprachiasmatic nucleus (SCN) is the master
pacemaker controlling daily rhythms in physiology and behavior
[1]. Circadian rhythms are generated in individual SCN neurons
via positive and negative feedback loops involving transcription
and translation of so-called clock genes [1,2]. The SCN is
composed of numerous single-cell oscillators that, when synchro-
nized, produce a coordinated circadian output. Neurochemical
and electrical signaling between SCN neurons is necessary for
these individual cellular clocks to coordinate their activities and
maintain robust oscillations [3–5]. One prominent feature of
neurons in the SCN is the circadian rhythm in spontaneous firing
rate which peaks during the light phase in nocturnal animals [5].
The firing rate of SCN neurons is clearly linked to behavioral and
physiological rhythms. The activity of the SCN is thought to
suppress daytime locomotor activity [6] by both direct innervation
[7] and via the actions of humoral transmitting molecules [8].
Recently, many neurochemical signals have been reported to
regulate the electrical activity of SCN neurons [9–16].
Prokineticin2 (PK2) has been identified as an output molecule of
the SCN and exhibits high circadian rhythmic expression in the
SCN [17–19]. Transcription of PK2 is tightly controlled by
components of the core molecular circadian oscillators [17]. PK2
mRNA expression levels are high during the day and low
throughout the night in the SCN of mice and rats [17,20–21].
Intracerbroventricular delivery of PK2 at night, when endogenous
levels are minimal, suppresses locomotor activity and feeding
behavior [17]. PK2-deficient mice exhibited significantly reduced
rhythmicity for a variety of physiological and behavioral
parameters, including sleep/wake cycle, locomotor activity,
feeding, and body temperature [22–23]. Prokineticin receptor 2
(PKR2), a receptor for PK2, has been shown to be expressed in
most primary target areas of the SCN by mRNA in situ
hybridization [20–21]. Recently, Zhang et al reported that PK2-
expressing neurons from the SCN projected to many known target
areas utilizing a bacterial artificial chromosome transgenic mouse
[24]. The circadian phenotypes of PKR2-mutant mice are almost
identical with that of PK2- deficient mice [25]. The targeted null
mutation of PKR2 disrupts circadian coordination of the activity
cycle and thermoregulation. Thus, PK2-PKR2 signaling is critical
for the maintenance of robust circadian rhythms.
PK2 has been shown to modulate the electrical activity of
neurons through the activation of PKR2 in the area postrema,
subfornical organ, and paraventricular nucleus of the hypothala-
mus [26–28]. Interestingly, PKR2 mRNA is also expressed in the
SCN [17,21], and PKR2 mRNA-containing neurons are clustered
in the dorsomedial region of the SCN [20], suggesting that these
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the SCN. In the present study, cell-attached recordings revealed
that PK2 increased spontaneous firing rate of dorsal SCN neurons,
and whole-cell voltage clamp recordings showed that PK2 reduced
the amplitude but not frequency of miniature inhibitory
postsynaptic currents (mIPSCs) in the SCN slices.
Results
PK2 caused an increased spontaneous firing rate in the
SCN neurons
Spontaneous firing in the neurons from the SCN was recorded
in the cell-attached configuration of the patch clamp technique.
We examined the effects of 10 min application of 0.1 nM PK2 on
spontaneous firing rate in eight SCN slices during daytime (ZT4–
8). PK2 caused an increased firing rate in eleven of 13 neurons
located within the dorsal region of SCN, and two neurons showed
no response. In the present study, we established a cut-off value for
the effect of PK2, which was at least a 10% the change in the firing
rate. Figure 1A and B showed the effect of PK2 on a representative
SCN neuron recorded with the cell-attached mode. Application of
0.1 nM PK2 increased the spontaneous firing rate from 7.4 to
13.6 Hz for this particular cell. In 11 neurons responding to PK2
with an increased firing rate, the onset of effect could be seen
during the 10 min period of PK2 exposure. Figure 1C illustrated
the time-effect relationship of 0.1 nM PK2 on changes in
spontaneous firing rate in eight neurons of the dorsal SCN. The
potentiation of PK2 on spontaneous firing reached a maximal
effect at 10 min after the onset of application, and firing rates
increased 67.367.7% of the control values of pre-drug. During
washout of PK2, spontaneous firing recovered gradually. The
effect of PK2 on SCN neurons was concentration dependent with
a maximal effect observed at 1 nM and a half-maximal response
(EC50) at 44.3 pM (Fig. 1D).
Effects of PK2 on the dorsal and ventral neurons of the
SCN
The dorsal and ventral regions of the SCN were defined as
described previously [29]. There was distinct localization of
prokineticin receptor 2 (PKR2) in the subregions of the SCN, and
the PKR2-expressed neurons were clustered in the dorsomedial
division [20]. Therefore, we compared the effect of PK2 on
spontaneous firing rate of the dorsal and ventral SCN. There was
not different in the baseline firing frequency between dorsal and
ventral SCN neurons in the 13 tested neurons during daytime
(ZT4–8). Howerer, the percentages of cells responding to 0.1 nM
PK2 were different between the dorsal and ventral neurons of the
SCN duringdaytime ((Fig. 2A)). Of all 13 neurons examined, eleven
cells (84.6%, 11/13) responded to PK2 with increased firing rate in
the dorsal SCN, whereas only three of 13 cells (23.1%, 3/13)
sensitive to PK2 in the ventral division (P,0.05, x
2 test). Neurons
that demonstrated at least a 10% the change in the firing rate were
considered ‘‘responders’’ in the present study. Thus, we performed
experiments in the dorsal division of the SCN unless otherwise
indicated.
Effect of PK2 on spontaneous firing rate during different
phases in the SCN neurons
The neurons from the SCN have a higher firing rate during the
day than at night [5]. And the PK2 expression in the SCN is
higher during the day. To see if PK2’s effect on the spontaneous
firing rate shows day-night variation, we investigated the effect of
PK2 during three different ZT phases. During the day (ZT 4–8),
Application of PK2 at low concentration (30 pM) increased the
Figure 1. Effect of PK2 on spontaneous firing in suprachiasmatic nuclei (SCN) neurons. (A) Firing rate histogram showing an example of a
neuron responding to PK2 (10 min treatment with 0.1 nM) with increased firing. (B) Representative traces of spontaneous activity from the cell with
the cell-attached mode in (A). (C) Time course of change in spontaneous firing rate from eight cells exposed to 0.1 nM PK2 for the duration indicated
by the length of the line. Data are represented as normalized mean 6 SEM. (D) Dose-response curve for the effect of PK2 on spontaneous firing rate.
EC50 was calculated to be 44.3 pM. Each point represents the normalized mean 6 SEM of 6–8 neurons. All firings were recorded in the dorsal division
of SCN during daytime (ZT 4–8).
doi:10.1371/journal.pone.0020263.g001
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test) (Fig. 2B). Similarly, PK2 treatment increased the firing rate
from 3.960.3 to 5.960.4 Hz (n=7, P,0.01, paired t-test) during
the early night (ZT 13–15) and from 3.560.3 to 5.460.5 Hz
(n=7, P,0.01, paired t-test) during the late night (ZT 20–22)
(Fig. 2B). Nevertheless, there was no temporal difference in the
absolute PK2-induced firing rate change. The ‘‘PK2 - control’’
differences for firing rate during three phases were 2.560.2,
2.060.2 and 1.960.2 Hz during the day, the early and late night,
respectively (Fig. 2C; P.0.05, analysis of variance).
PK2 reduced the amplitude but not frequency of mIPSCs
in the SCN
To test whether the effects of PK2 on spontaneous firing were
associated with changes in synaptic transmission, we performed
recordings of mIPSCs from neurons in the dorsal SCN using
whole cell voltage-clamp technique during daytime (ZT 4–8). The
mIPSCs were pharmacologically isolated by applying a combina-
tion of APV (50 mM) and DNQX (10 mM) to block NMDA and
AMPA/kainite receptors, respectively, and TTX (1 mM) to block
Na
+ channel-mediated action potentials and the postsynaptic Na
+
currents from them. All remaining currents were GABAA-
receptor-mediated currents and could be suppressed by the
GABAA receptor antagonist bicuculline (30 mM) (Fig. 3). The
mIPSCs recording in this manner appear as inward currents, since
the holding potential (270 mV) was more negative than the
chloride equilibrium potential. Bath application of 0.1 nM PK2
for 10 min was found to reduce the amplitudes of mIPSCs, but did
not affect their frequency (Fig. 3A and B). During washout of PK2,
The mIPSC amplitude recovered partially. The effect of PK2 was
widespread in the dorsal SCN. In ten of the neurons examined,
eight cells responded to PK2 exposure. The average amplitudes of
mIPSC for these eight cells in the presence of PK2 decreased to
65.767.2% of the control period (P,0.01, paired t-test), and the
average frequency was 107.4613.4% of the control period
(P.0.05, paired t-test). The remaining two cells were not sensitive
to PK2 and changes in the average amplitude and frequency were
within 5%. If we consider all ten cells tested as a single population,
then PK2 caused a 28.163.4% reduction in the average
amplitudes of mIPSC (P,0.01, paired t-test). Figure 3C showed
the average mIPSC amplitude distribution of the neuron tested for
the control and PK2 condition in a cumulative fraction plot. PK2
caused a shift of the curve towards smaller amplitudes. In contrast,
PK2 did not affect the frequency of mIPSCs as shown in a
cumulative fraction plot for the averaged interevent interval for
each condition (Fig. 3D). In addition, PK2 did not alter mIPSC
kinetics and no difference was found in the rise time constants
(2.160.2 ms with PK2 pretreatment vs. 2.060.2 ms without PK2
pretreatment) and decay time constants (20.661.9 ms with PK2
pretreatment vs. 22.462.3 ms without PK2 pretreatment) of
mIPSC after treatment of PK2.
PK2 inhibited exogenous GABA-induced currents in SCN
neurons
We previously reported that PK2 depresses GABA-induced
currents in the primary sensory neurons [30]. To further
Figure 2. Effects of PK2 on spontaneous firing in different the SCN sub-regions and different the phases. (A) A majority of neurons (11/
13) responded to 0.1 nM PK2 with increased firing rate in the dorsal division of SCN, in contrast, only three of 13 cells sensitive to PK2 in the ventral
division. Cells that demonstrated at least a 10% the change in the firing rate were considered ‘‘responders’’. (B) PK2 (30 pM) increased firing rate of
SCN neurons during three phases, day (ZT 4–8), early night (ZT 13–15), and late night (ZT 20–22). Each pair represents the firing rate of a neuron
before and after PK2 treatment. (C) The histogram showing the ‘‘PK2 - Control’’ differences for firing rate during three phases in (B). There was no
difference between the day, early and late night (n=7, P.0.05, analysis of variance).
doi:10.1371/journal.pone.0020263.g002
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receptor signaling in SCN neurons, we next examined the effect of
PK2 on exogenous GABA-induced currents. Exogenous applica-
tion of GABA (0.1 mM) produced an inward current at holding
potential 270 mV in SCN neurons during the day. This GABA-
evoked current could be blocked by GABAA receptor antagonist
bicuculline (30 mM). Pre-treatment with 0.1 nM PK2 for 10 min,
peak GABA-induced currents were significantly different of those
observed before application of PK2. The amplitude of GABA-
activated currents decreased to 66.965.2% of the control in seven
neurons tested (Fig. 4). Thus PK2 may act at the postsynaptic
GABAA receptor.
Depression of GABAA receptor-mediated current by PK2
required postsynaptic kinase C
PKR2, a receptor of PK2, belongs to Gq protein-coupled
receptors and mainly expresses in dorsomedial SCN neurons [20].
Next we analyzed intracellular signal route concerned in the
suppression of GABAA receptor-mediated current by PK2.
GF109203 X (2 mM), a selective PKC inhibitor, was applied
internally to SCN neurons through recording patch pipettes. PK2
(0.1 nM) did not depress mIPSCs in seven neurons treated with
GF109203X, and the change in average amplitude of mIPSCs was
5.764.1%. In contrast, PK2 (0.1 nM) caused a 31.163.8% (n=7)
depression of mIPSCs when the pipette filled with normal internal
solution (P,0.01, t-test). The baseline frequency and average
amplitude of mIPSCs were not different in the presence and
absence of GF109203X, and the changes induced by GF109203X
were within 3.0%. Intracellular application of GF109203X did not
alter mIPSC kinetics. Similarly, the effect of PK2 on exogenous
GABA-evoked currents was also prevented by the internal
treatment of GF109203 X. PK2 caused only a 9.764.1% (n=7)
depressive effect on exogenous GABA-evoked currents in neurons
treated with GF109203 X, while PK2 depressed GABA-evoked
currents by 33.165.2% (n=7) when the pipette filled with internal
solution (P,0.01, t-test). Thus, PKC may play a key role in the
regulation of GABAA receptor in SCN neurons.
Discussion
These data demonstrated the effects of PK2 on electrical activity
of rat SCN neurons. Firstly, PK2 dose-dependently increased the
spontaneous firing rate of SCN neurons, and the proportion of
cells responding to PK2 was greater in the dorsal region than the
ventral region. Secondly, PK2 inhibited GABAA-receptor signal-
ing within the SCN. The site of PK2 action was postsynaptic, since
PK2 reduced the amplitude but not frequency of mIPSCs.
Furthermore, PK2 also suppressed exogenous GABA-induced
currents. Finally, the inhibitory effect of PK2 required PKC
activation in the postsynaptic cells.
It is reported that PK2 produces an excitatory role on the other
neurons from subfornical organ and paraventricular nucleus of the
hypothalamus through depolarizing membrane potentials and
modulating Na
+ channels [27–28]. As the PKR2 is highly
expressed in the SCN, the effect of PK2 on SCN neurons may
be mediated by PKR2. The SCN consists of two morphologically
and functionally distinct regions, the ventrolateral (or core) and
dorsomedial (or shell) SCN [31–32]. These two regions have
distinct afferent inputs. The ventrolateral region receives direct
input from the retina through the retinohypothalamic tract (RHT)
and is thus photo-responsive [31]. In contrast, the dorsomedial
region, lacking the projection from outside of the SCN, is
modulated by entraining input from the ventrolateral region
Figure 3. Effect of PK2 on GABAA receptor-mediated miniature inhibitory postsynaptic currents (mIPSCs) recorded from rat SCN
neurons. (A) Representative current traces showing mIPSCs obtained under control conditions, during application of 0.1 nM PK2 and washout
conditions. The slice was bathed in AP5 (50 mM), DNQX (10 mM), and TTX (1 mM). The holding potential was 270 mV. Bath application of 10
210 M PK2
for 10 min reduced the amplitudes of mIPSCs, but did not affect their frequency. During washout of PK2, there was a partial recovery of mIPSC
amplitude. The mIPSCs were blocked by 30 mM bicuculline. (B) Average mIPSC waveforms of 300 randomly selected mIPSCs for each condition. (C, D)
Cumulative event amplitude and inter-event interval plots for the neuron in A before and after PK2 application. PK2 caused a leftward shift in the
amplitude but not interval distribution indicating that PK2 decreased the amplitude of mIPSC without altering the frequency.
doi:10.1371/journal.pone.0020263.g003
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clustered in the dorsomedial region of the SCN [20]. In the
present study, the majority of neurons responding to PK2 located
in the dorsal SCN, suggesting that the effect of PK2 was mainly
restricted to dorsal region, consistent with the localization of
PKR2 mRNA in the SCN. PK2, as an output molecule, is highly
expressed in the SCN and its mRNA level displays a robust
circadian oscillation with a peak occurring during the day [17].
PK2 mRNA-positive neurons are scattered in both the dorsome-
dial and ventrolateral SCN [20]. Thus, PK2 neurons may
intrinsically project to the PKR2-expressing neurons in the dorsal
SCN. Rhythmicity of neuronal activity in the SCN relies on both
intrinsic currents that generate the day-night difference in activity,
as well as intercellular communication to synchronize the rhythms
of individual neurons. Our data indicated that PK2-PKR2
signaling may play an important modulatory role in regulating
cell-to-cell communication within the SCN. Spontaneous firings in
the SCN show a diurnal pattern. Neurons are more active during
the day, and activity is suppressed at night [6–7]. Recently, Belle et
al reported that per1 cells were completely silent during the
afternoon and early night and showed different daily variation in
firing frequency compared to non-per1 cells in the SCN [34]. In
the present study, the firing patterns of neurons recorded were
similar to the patterns of non-per1 cells, with high rates during the
day and lower rates at night. In the SCN, the enhanced effect of
PK2 on spontaneous firing was consistent with higher firing rates
and PK2 mRNA expression levels during the day.
It is widely accepted that most SCN neurons are GABA-ergic
and this transmitter plays an important role in coordinating
interneuronal communication both within and between dorsal and
ventral SCN subcompartments [35–36]. SCN neurons are under
tonic GABAergic control and receive a high frequency of GABAA-
mediated postsynaptic currents [37–40] that at least partly
originate within the SCN itself [41]. Most studies examining the
effects of GABA on rodent SCN neurons demonstrate that its
actions are inhibitory and are predominantly mediated via
GABAA receptors [5,42–43]. We previously reported that PK2
depresses GABA-induced currents in the primary sensory neurons
[30]. In agreement with the enhanced effect of PK2 on firing rate,
we observed that PK2 reduced the amplitude of mIPSCs through
suppressive GABAA receptor signaling in the SCN. It is therefore
likely that PK2 gives rise to changes in firing rate by influencing
synaptic strength and suppressing GABAergic inhibition within
the SCN. In the present study, we confirmed that PK2 depressed
postsynaptic sensitivity of GABAA receptors, rather than changing
the release of GABA by demonstrating that it reduced amplitude
but not the frequency of mIPSCs. The postsynaptic depressant
effect of PK2 on GABAergic synapses was further supported by
the observation that PK2 decreased postsynaptic responses to
exogenously applied GABA.
The inhibition of PK2 on the GABAA receptors-medicated
currents appeared to involve PKC signal pathway, since this effect
was completely prevented by abolishing postsynaptic PKC
activation with the selective PKC inhibitor GF109203 X. PKR2
is the most likely target to mediate PK2 inhibitory effect on GABA
currents, since PKR2 mRNA is highly expressed in the
dorsomedial region of the SCN [20]. PKR2 belongs to the G-
protein receptor and is couple to Gq protein to mediate the
intracellular calcium mobilization and the activation of PKC [44–
46]. There are already good evidences that GABA currents are
negatively regulated by PKC [47–49]. Henneberger et al [50]
reported that BDNF reduced mIPSC amplitudes in a PKC
dependent manner in superior colliculus slices. The observation
that PK2 decreased GABAergic mIPSCs may due to PKC-
mediated internalization, rather than phosphorylation of GABAA
receptors, since no changes were found in the kinetics of mIPSCs.
It is shown that the cell surface stability of GABAA receptors
depends on PKC activity [51–53] and GABAA receptor numbers
in the plasma membrane were reduced on PKC activation [54].
In summary, we showed that PK2 increased the spontaneous
firing rate and inhibited GABAA-receptor signaling within the
SCN. Such effect on SCN neuronal activity may influence
behavioral and physiological rhythms.
Materials and Methods
Animals
All experiments were approved by the Institutional Animal Care
and Use Committee of Xianning College (approval no. 1016) and
were carried out in strict accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals. Male
Sprague-Dawley rats (17–26 day) were housed under a 12 : 12
light : dark cycle (light on 7:00 am–7:00 pm) at an ambient
temperature of 2261uC. Food and water were available ad libitum.
Zeitgeber time (ZT) 0 was defined as lights-on and ZT 12 as lights-
off. Animals were maintained under these conditions for .10 days
prior to experimental protocols.
SCN slice preparation
Slices were prepared during the day (ZT2), early night (ZT11)
or late night (ZT18), and maintained using methods similar to
those described earlier [11,29]. Rats were decapitated under deep
isofluorane anesthesia. Brains were then rapidly dissected and
immersed in ice-cold artificial cerebral spinal fluid (ACSF) pre-
Figure 4. Inhibition effect of PK2 on exogenous GABA-induced
currents in SCN neurons. (A) The inward currents were elicited by
0.1 mM GABA in a SCN neuron voltage clamped at 270 mV. PK2
exerted an inhibitory effect on the GABA-activated current. PK2 (0.1 nM)
was pre-applied to external solution for 10 min. The GABA-activated
current could be blocked by 30 mM bicuculline. (B) A summary bar
graph showing PK2 had significant effect on the responses to
exogenous application of GABA (*P,0.05, n=7).
doi:10.1371/journal.pone.0020263.g004
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NaCl, 3.5 mM KCl, 2 mM CaCl2, 1.5 mM MgCl2,2 6 m M
NaHCO3, 1.2 mM NaH2PO4, and 10 mM glucose. Coronal slices
(200–300 mm) containing the SCN and the optic chiasm were cut
using a vibroslicer (Campden Instruments, Leicester, UK). Slices
were then transferred to holding chamber and incubated for .1h
in oxygenated ACSF at 36uC before the start of electrophysiolog-
ical experiments. The ventral or dorsal region of the SCN is
defined as the upper or lower one third of the SCN, by drawing
two imaginary lines parallel to the optic chiasm and dividing the
SCN into three approximately equal-size divisions [11,29].
Electrophysiological recordings and data analysis
All experiments were performed during the daytime (ZT 4–8),
unless stated as early night (ZT13–15) or late night (ZT 20–22).
Slices were continuously perfused (,1.5 ml/min) with oxygenated
ACSF and maintained at a temperature of 36uC. Electrodes
(resistance 4–6 MV) were pulled from borosilicate (1.5 mm OD)
on a horizontal puller (P-97; Sutter Instrument, CA, USA). The
spontaneous firing was recorded in the cell-attached voltage-clamp
mode without membrane breakthrough. The patch electrode
solution was the same as the bath solution. The spike counts, in 6-
sepochs, always began only after stable recordings were made. At
least 1 or 2 min of spontaneous firing rate were counted before the
application of drugs. Whole-cell recordings were made in voltage-
clamp mode at a holding potential of 270 mV for analysis of
postsynaptic currents. Pipettes were filled with a solution
containing (in mM) 130 CsCl, 10 HEPES, 1 NaCl, 1 CaCl2,1
MgCl2, 5 EGTA, 2 ATP, 0.2 GTP, and 5 QX314, and pH
adjusted to 7.2–7.3 with CsOH. Whole cell patch-clamp
recordings were made using infrared illumination with differential
interference contrast optics (IR-DIC) video microscopy. Seal
resistances were typically 1–4 GV, and series resistances were
,20 MV. Whole cell currents were amplified with an Axopatch-
Multiclamp700A amplifier (Axon Instruments) and digitized with
a Digidata 1440A (Axon Instruments). Records were collected and
stored onto a PC using the pCLAMP 8.0 software (Axon
Instruments). Miniature IPSCs were isolated by using the
glutamate AMPA/kainite receptor antagonist, 5,7-dinitroquinoxa-
line-2,3-dione (DNQX; 10 mM), the N-methyl-D-aspartate
(NMDA) receptor antagonist DL-2-amino-5- phosphonopentanoi-
cacid (APV; 50 mM), and tetrodotoxin (TTX; 1 mM). All
parameters of postsynaptic currents were analyzed off-line with
Mini-Analysis software (Synaptosoft). All values are given as mean




PK2 was obtained from our lab. DNQX, APV, TTX, GABA,
and GF109203 X were purchased from RBI/Sigma. All drugs
were dissolved daily just before use and applied to the cells by bath
perfusion of slices with ACSF containing the concentration of the
drug, but GF109203X that needed to be applied intracellularly
was dissolved in the internal solution.
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